| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 3/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
Hisamitsu Pharmaceutical Co., Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥3,717.00 |
| 52 Week High | JP¥5,497.00 |
| 52 Week Low | JP¥3,600.00 |
| Beta | 0.39 |
| 11 Month Change | 1.23% |
| 3 Month Change | -6.44% |
| 1 Year Change | -1.41% |
| 33 Year Change | -32.05% |
| 5 Year Change | -17.03% |
| Change since IPO | 742.86% |
Recent News & Updates
Hisamitsu Pharmaceutical's (TSE:4530) Dividend Will Be Increased To ¥45.00
Jun 27
Hisamitsu Pharmaceutical (TSE:4530) Is Increasing Its Dividend To ¥45.00
Jun 13Recent updates
Hisamitsu Pharmaceutical's (TSE:4530) Dividend Will Be Increased To ¥45.00
Jun 27Hisamitsu Pharmaceutical (TSE:4530) Is Increasing Its Dividend To ¥45.00
Jun 13Why We're Not Concerned About Hisamitsu Pharmaceutical Co., Inc.'s (TSE:4530) Share Price
Apr 09Here's Why We Think Hisamitsu Pharmaceutical (TSE:4530) Is Well Worth Watching
Mar 18Shareholder Returns
| 4530 | JP Pharmaceuticals | JP Market | |
|---|---|---|---|
| 7D | 2.2% | 4.7% | 2.9% |
| 1Y | -1.4% | 7.5% | 20.0% |
Return vs Industry: 4530 underperformed the JP Pharmaceuticals industry which returned 6.2% over the past year.
Return vs Market: 4530 underperformed the JP Market which returned 19.2% over the past year.
Price Volatility
| 4530 volatility | |
|---|---|
| 4530 Average Weekly Movement | 2.3% |
| Pharmaceuticals Industry Average Movement | 3.9% |
| Market Average Movement | 3.9% |
| 10% most volatile stocks in JP Market | 7.3% |
| 10% least volatile stocks in JP Market | 2.0% |
Stable Share Price: 4530 has not had significant price volatility in the past 3 months.
Volatility Over Time: 4530's weekly volatility (2%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1847 | 2,759 | Kazuhide Nakatomi | www.global.hisamitsu |
Hisamitsu Pharmaceutical Co., Inc. manufactures and sells pharmaceuticals in Japan. The company provides external pain-relieving drugs under the SALONPAS, NOBINOBI, SALONSIP, AIR, SALONPAS, and FEITAS; BUTENALOCK, a remedy for athlete's foot; and ALLEGRA FX, a sinus medication for allergies. It also manufactures and sells quasi-drugs and cosmetics; MOHRUS TAPE and MOHRUS PAP XR, a transdermal analgesic anti-inflammatory drug; and patches for female hormone, asthma, and overactive bladders.
Hisamitsu Pharmaceutical Co., Inc. Fundamentals Summary
| 4530 fundamental statistics | |
|---|---|
| Market cap | JP¥272.62b |
| Earnings (TTM) | JP¥13.97b |
| Revenue (TTM) | JP¥141.71b |
19.5x
P/E Ratio1.9x
P/S RatioIs 4530 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 4530 income statement (TTM) | |
|---|---|
| Revenue | JP¥141.71b |
| Cost of Revenue | JP¥62.74b |
| Gross Profit | JP¥78.97b |
| Other Expenses | JP¥65.00b |
| Earnings | JP¥13.97b |
Last Reported Earnings
Feb 29, 2024
Next Earnings Date
Jul 11, 2024
| Earnings per share (EPS) | 190.46 |
| Gross Margin | 55.73% |
| Net Profit Margin | 9.86% |
| Debt/Equity Ratio | 0.4% |
How did 4530 perform over the long term?
See historical performance and comparisonDividends
2.3%
Current Dividend Yield47%
Payout RatioDoes 4530 pay a reliable dividends?
See 4530 dividend history and benchmarks| Hisamitsu Pharmaceutical dividend dates | |
|---|---|
| Ex Dividend Date | Aug 29 2024 |
| Dividend Pay Date | Nov 07 2024 |
| Days until Ex dividend | 60 days |
| Days until Dividend pay date | 130 days |
Does 4530 pay a reliable dividends?
See 4530 dividend history and benchmarks